Skip to content
Search for:
The Society
Board of Directors
Scientific Advisory Council
Contact
Events Calendar
Mentorship Program
Rare Disease Task Force
BOD Trainee Representatives
Awards & Grants
Lifetime Achievement Award
Young Investigator Award
Dr. Alan M. Gewirtz Memorial Scholarships
Award for Science Outreach or Patient Advocacy
Paper of the Year Awards
Poster Awards
Local & Regional Delivery Grants
Travel Grants
Science News
Recent Articles
President’s Pick and Perspective
Journal
Archive
Educational Video Library
OSWG Whitepapers
Support for Ukrainian Scientists
Job Board
Employer Profiles
Employer Registration / Login
Events
Annual Meetings
Past Annual Meetings
2024 Annual Meeting
2023 Annual Meeting
2022 Annual Meeting
2021 Annual Meeting
2020 Annual Meeting
Webinars
Events Calendar
Membership
Become A Member or Renew Membership
Featured Members
Search for:
Pharmacokinetics of Patisiran, the First Approved RNA Interference Therapy in Patients With Hereditary Transthyretin-Mediated Amyloidosis.
OTS
Ago/siRNA/saRNA
,
Clinical Development
,
Delivery
,
Hot Papers
November 30, 2019
SHARE
Post Views:
916
Zhang X, Goel V, Robbie GJ.
J Clin Pharmacol. 2019 Nov 27.
PubMed
Previous
Next
Related articles
Flash Synthesis of Spherical Nucleic Acids with Record DNA Density
Flash Synthesis of Spherical Nucleic Acids with Record DNA Density
April 23rd, 2021
Tilsotolimod with ipilimumab drives tumor responses in anti-PD-1 refractory melanoma
Tilsotolimod with ipilimumab drives tumor responses in anti-PD-1 refractory melanoma
April 23rd, 2021
Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy
Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy
April 23rd, 2021
Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy
Targeted In Vivo Delivery of NF-κB Decoy Inhibitor Augments Sensitivity of B Cell Lymphoma to Therapy
April 23rd, 2021
Non-specific interactions of antibody-oligonucleotide conjugates with living cells
Non-specific interactions of antibody-oligonucleotide conjugates with living cells
April 23rd, 2021
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown
April 23rd, 2021
Page load link
Go to Top